檢索結果 - Perrot, Aurore

Revised international staging system allocation in the ICARIA‐MM study: Practical challenges and impact on outcome 由 Richardson, Paul G., Perrot, Aurore, Takamatsu, Hiroyuki

獲取全文 獲取全文 獲取全文

Vaccination during the First Diagnosis of Multiple Myeloma: A Cohort Study of the French National Health Insurance Database 由 Tournaire, Guilhem, Conte, Cécile, Perrot, Aurore, Lapeyre-Mester, Maryse, Despas, Fabien

獲取全文 獲取全文 獲取全文

Multiple Myeloma: Heterogeneous in Every Way 由 Schavgoulidze, Anaïs, Cazaubiel, Titouan, Perrot, Aurore, Avet-Loiseau, Hervé, Corre, Jill

獲取全文 獲取全文 獲取全文

When dystrophic plasma cells do not recognize themselves in the mirror 由 Rieu, Jean‐Baptiste, Perrot, Aurore, Vergez, Francois, Largeaud, Laetitia, Corre, Jill

獲取全文 獲取全文 獲取全文

Risk and Response-Adapted Treatment in Multiple Myeloma 由 Cazaubiel, Titouan, Mulas, Olga, Montes, Lydia, Schavgoulidze, Anaïs, Avet-Loiseau, Hervé, Corre, Jill, Perrot, Aurore

獲取全文 獲取全文 獲取全文

Lactic acidosis and hypoglycemia as markers of disease progression of multiple myeloma: A case report 由 Ziegler, Caroline, Volkov, Lev, Marnai, Rémy, Courte, Guilhem, Cravoisy, Aurélie, Conrad, Marie, Nace, Lionel, Melone, Agnès, Perrot, Aurore, Gibot, Sébastien

獲取全文 獲取全文 獲取全文

Variable BCL2/BCL2L1 ratio in multiple myeloma with t(11;14) 由 Cleynen, Alice, Samur, Mehmet, Perrot, Aurore, Buisson, Laure, Maheo, Sabrina, Fulciniti, Mariateresa, Attal, Michel, Munshi, Nikhil, Avet-Loiseau, Hervé, Corre, Jill

獲取全文 獲取全文 獲取全文

Impact of post-brentuximab vedotin consolidation on relapsed/refractory CD30(+) Hodgkin lymphomas: a large retrospective study on 240 patients enrolled in the French Named-Patient... 由 Perrot, Aurore, Monjanel, Hélène, Bouabdallah, Réda, Quittet, Philippe, Sarkozy, Clémentine, Bernard, Marc, Stamatoullas, Aspasia, Borel, Cécile, Bouabdallah, Krimo, Nicolas-Virelizier, Emmanuelle, Fournier, Marion, Morschhauser, Franck, Brice, Pauline

獲取全文 獲取全文 獲取全文

A unique proteomic profile on surface IgM ligation in unmutated chronic lymphocytic leukemia 由 Perrot, Aurore, Pionneau, Cédric, Nadaud, Sophie, Davi, Frédéric, Leblond, Véronique, Jacob, Frédéric, Merle-Béral, Hélène, Herbrecht, Raoul, Béné, Marie-Christine, Gribben, John G., Bahram, Seiamak, Vallat, Laurent

獲取全文 獲取全文 獲取全文

Myeloma MRD by deep sequencing from circulating tumor DNA does not correlate with results obtained in the bone marrow 由 Mazzotti, Céline, Buisson, Laure, Maheo, Sabrina, Perrot, Aurore, Chretien, Marie-Lorraine, Leleu, Xavier, Hulin, Cyrille, Manier, Salomon, Hébraud, Benjamin, Roussel, Murielle, Do Souto, Laura, Attal, Michel, Avet-Loiseau, Hervé, Corre, Jill

獲取全文 獲取全文 獲取全文

Obinutuzumab and idelalisib in symptomatic patients with relapsed/refractory Waldenström macroglobulinemia 由 Tomowiak, Cécile, Poulain, Stéphanie, Herbaux, Charles, Perrot, Aurore, Mahé, Béatrice, Morel, Pierre, Aurran, Thérèse, Tournilhac, Olivier, Leprêtre, Stéphane, Assaad, Souad, Villemagne, Bruno, Casasnovas, Olivier, Nollet, Delphine, Roos-Weil, Damien, Chevret, Sylvie, Leblond, Véronique

獲取全文 獲取全文 獲取全文

Infradiaphragmatic Hodgkin lymphoma: a large series of patients staged with PET-CT 由 Rossi, Cédric, Mounier, Morgane, Brice, Pauline, Safar, Violaine, Nicolas-Virelizier, Emmanuelle, Rey, Philippe, Stamatoullas-Bastard, Aspasia, Alcantara, Marion, Chauchet, Adrien, Reboursière, Emilie, Filliatre, Lauriane, Perrot, Aurore, Garciaz, Sylvain, Salles, Gilles, Coiffier, Bertrand, Ghesquières, Hervé, Casasnovas, René-Olivier

獲取全文 獲取全文 獲取全文

All-oral triplet combination of ixazomib, lenalidomide, and dexamethasone in newly diagnosed transplant-eligible multiple myeloma patients: final results of the phase II IFM 2013-0... 由 Touzeau, Cyrille, Perrot, Aurore, Roussel, Murielle, Karlin, Lionel, Benboubker, Lotfi, Jacquet, Caroline, Mohty, Mohamad, Facon, Thierry, Manier, Salomon, Chretien, Marie-Lorraine, Tiab, Mourad, Hulin, Cyrille, Leleu, Xavier, Loiseau, Hervé Avet, Dejoie, Thomas, Planche, Lucie, Attal, Michel, Moreau, Philippe

獲取全文 獲取全文 獲取全文

Subgroup analysis of ICARIA‐MM study in relapsed/refractory multiple myeloma patients with high‐risk cytogenetics 由 Harrison, Simon J., Perrot, Aurore, Alegre, Adrian, Simpson, David, Wang, Ming Chung, Spencer, Andrew, Delimpasi, Sosana, Hulin, Cyrille, Sunami, Kazutaka, Facon, Thierry, Vlummens, Philip, Yong, Kwee, Campana, Frank, Inchauspé, Marlène, Macé, Sandrine, Risse, Marie‐Laure, van de Velde, Helgi, Richardson, Paul

獲取全文 獲取全文 獲取全文

Central nervous system relapse in patients over 80 years with diffuse large B‐cell lymphoma: an analysis of two LYSA studies 由 Cabannes‐Hamy, Aurélie, Peyrade, Frederic, Jardin, Fabrice, Emile, Jean‐François, Delwail, Vincent, Mounier, Nicolas, Haioun, Corinne, Perrot, Aurore, Fitoussi, Olivier, Lara, Diane, Delarue, Richard, André, Marc, Offner, Fritz, Ghesquières, Hervé, Pascal, Laurent, Soussain, Carole, Lazarovici, Julien, Schiano, Jean‐Marc, Gaulard, Philippe, Tilly, Hervé, Thieblemont, Catherine

獲取全文 獲取全文 獲取全文

A phase 2 study of isatuximab monotherapy in patients with multiple myeloma who are refractory to daratumumab 由 Mikhael, Joseph, Belhadj-Merzoug, Karim, Hulin, Cyrille, Vincent, Laure, Moreau, Philippe, Gasparetto, Cristina, Pour, Ludek, Spicka, Ivan, Vij, Ravi, Zonder, Jeffrey, Atanackovic, Djordje, Gabrail, Nashat, Martin, Thomas G., Perrot, Aurore, Bensfia, Samira, Weng, Qilong, Brillac, Claire, Semiond, Dorothée, Macé, Sandrine, Corzo, Kathryn P., Leleu, Xavier

獲取全文 獲取全文 獲取全文

A susceptibility locus for classical Hodgkin lymphoma at 8q24 near MYC/PVT1 predicts patient outcome in two independent cohorts 由 Ghesquières, Hervé, Larrabee, Beth R., Casasnovas, Olivier, Maurer, Matthew J., McKay, James D., Ansell, Stephen M., Montgomery, Dorothy, Asmann, Yan W., Farrell, Katrina, Verney, Aurélie, Slager, Susan L., Allmer, Cristine, Perrot, Aurore, Delarue, Richard, Habermann, Thomas M., Dupuis, Jehan, Link, Brian K., Canioni, Danielle, Dogan, Ahmet, Cozen, Wendy, Jarrett, Ruth F., Cerhan, James R., Salles, Gilles

獲取全文 獲取全文 獲取全文

del(17p) without TP53 mutation confers a poor prognosis in intensively treated newly diagnosed patients with multiple myeloma 由 Corre, Jill, Perrot, Aurore, Caillot, Denis, Belhadj, Karim, Hulin, Cyrille, Leleu, Xavier, Mohty, Mohamad, Facon, Thierry, Buisson, Laure, Do Souto, Laura, Lannes, Romain, Dufrechou, Stephanie, Prade, Naïs, Orsini-Piocelle, Frederique, Voillat, Laurent, Jaccard, Arnaud, Karlin, Lionel, Macro, Margaret, Brechignac, Sabine, Dib, Mamoun, Sanhes, Laurence, Fontan, Jean, Clement-Filliatre, Lauriane, Marolleau, Jean-Pierre, Minvielle, Stephane, Moreau, Philippe, Avet-Loiseau, Hervé

獲取全文 獲取全文 獲取全文

Health-Related Quality of Life in Transplant-Ineligible Patients With Newly Diagnosed Multiple Myeloma: Findings From the Phase III MAIA Trial 由 Perrot, Aurore, Facon, Thierry, Plesner, Torben, Usmani, Saad Z., Kumar, Shaji, Bahlis, Nizar J., Hulin, Cyrille, Orlowski, Robert Z., Nahi, Hareth, Mollee, Peter, Ramasamy, Karthik, Roussel, Murielle, Jaccard, Arnaud, Delforge, Michel, Karlin, Lionel, Arnulf, Bertrand, Chari, Ajai, He, Jianming, Ho, Kai Fai, Van Rampelbergh, Rian, Uhlar, Clarissa M., Wang, Jianping, Kobos, Rachel, Gries, Katharine S., Fastenau, John, Weisel, Katja

獲取全文 獲取全文 獲取全文

A predictive model for risk of early grade ≥ 3 infection in patients with multiple myeloma not eligible for transplant: analysis of the FIRST trial 由 Dumontet, Charles, Hulin, Cyrille, Dimopoulos, Meletios A., Belch, Andrew, Dispenzieri, Angela, Ludwig, Heinz, Rodon, Philippe, Van Droogenbroeck, Jan, Qiu, Lugui, Cavo, Michele, Van de Velde, Ann, Lahuerta, Juan José, Allangba, Olivier, Lee, Jae Hoon, Boyle, Eileen, Perrot, Aurore, Moreau, Philippe, Manier, Salomon, Attal, Michel, Roussel, Murielle, Mohty, Mohamad, Mary, Jean Yves, Civet, Alexandre, Costa, Bruno, Tinel, Antoine, Gaston-Mathé, Yann, Facon, Thierry

獲取全文 獲取全文 獲取全文